161 related articles for article (PubMed ID: 20571806)
1. [Systemic voclosporin for uveitis treatment].
Deuter CM
Ophthalmologe; 2010 Jul; 107(7):672-5. PubMed ID: 20571806
[TBL] [Abstract][Full Text] [Related]
2. A new agent for the treatment of noninfectious uveitis: rationale and design of three LUMINATE (Lux Uveitis Multicenter Investigation of a New Approach to Treatment) trials of steroid-sparing voclosporin.
Anglade E; Aspeslet LJ; Weiss SL
Clin Ophthalmol; 2008 Dec; 2(4):693-702. PubMed ID: 19668418
[TBL] [Abstract][Full Text] [Related]
3. A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis.
Rovin BH; Solomons N; Pendergraft WF; Dooley MA; Tumlin J; Romero-Diaz J; Lysenko L; Navarra SV; Huizinga RB;
Kidney Int; 2019 Jan; 95(1):219-231. PubMed ID: 30420324
[TBL] [Abstract][Full Text] [Related]
4. ISA 247: trans-ISA 247, trans-R 1524, ISA(TX)247, ISAtx 247, ISATx247, LX 211, LX211, R 1524, R-1524.
Drugs R D; 2007; 8(2):103-12. PubMed ID: 17324008
[TBL] [Abstract][Full Text] [Related]
5. [Therapy of intermediate uveitis].
Doycheva D; Deuter C; Zierhut M
Ophthalmologe; 2014 Dec; 111(12):1219-32; quiz 1233-4. PubMed ID: 25448321
[TBL] [Abstract][Full Text] [Related]
6. Oral voclosporin: novel calcineurin inhibitor for treatment of noninfectious uveitis.
Roesel M; Tappeiner C; Heiligenhaus A; Heinz C
Clin Ophthalmol; 2011; 5():1309-13. PubMed ID: 21966207
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of intravenous secukinumab in noninfectious uveitis requiring steroid-sparing immunosuppressive therapy.
Letko E; Yeh S; Foster CS; Pleyer U; Brigell M; Grosskreutz CL;
Ophthalmology; 2015 May; 122(5):939-48. PubMed ID: 25638011
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal Sirolimus for Noninfectious Uveitis: A Phase III Sirolimus Study Assessing Double-masKed Uveitis TReAtment (SAKURA).
Nguyen QD; Merrill PT; Clark WL; Banker AS; Fardeau C; Franco P; LeHoang P; Ohno S; Rathinam SR; Thurau S; Abraham A; Wilson L; Yang Y; Shams N;
Ophthalmology; 2016 Nov; 123(11):2413-2423. PubMed ID: 27692526
[TBL] [Abstract][Full Text] [Related]
9. LX211 (voclosporin) suppresses experimental uveitis and inhibits human T cells.
Cunningham MA; Austin BA; Li Z; Liu B; Yeh S; Chan CC; Anglade E; Velagaleti P; Nussenblatt RB
Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):249-55. PubMed ID: 18708627
[TBL] [Abstract][Full Text] [Related]
10. Systemic calcineurin inhibitors tacrolimus and voclosporin: A review of off-label dermatologic uses.
Dai A; Kim SJ
J Am Acad Dermatol; 2024 Feb; 90(2):358-367. PubMed ID: 37307993
[TBL] [Abstract][Full Text] [Related]
11. A masked, randomized, dose-response study between cyclosporine A and G in the treatment of sight-threatening uveitis of noninfectious origin.
Nussenblatt RB; de Smet MD; Rubin B; Freidlin V; Whitcup SM; Davis J; Herman D; Bloom JN; Sran PK; Whitcher S
Am J Ophthalmol; 1993 May; 115(5):583-91. PubMed ID: 8488909
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes of cyclosporine treatment for noninfectious uveitis.
Lee SH; Chung H; Yu HG
Korean J Ophthalmol; 2012 Feb; 26(1):21-5. PubMed ID: 22323881
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporine: A Historical Perspective on Its Role in the Treatment of Noninfectious Uveitis.
Smith WM
J Ocul Pharmacol Ther; 2017 May; 33(4):247-262. PubMed ID: 28287852
[TBL] [Abstract][Full Text] [Related]
14. Low-dose cyclosporine treatment for sight-threatening uveitis: efficacy, toxicity, and tolerance.
Mathews D; Mathews J; Jones NP
Indian J Ophthalmol; 2010; 58(1):55-8. PubMed ID: 20029146
[TBL] [Abstract][Full Text] [Related]
15. Effect of Adalimumab on Visual Functioning in Patients With Noninfectious Intermediate Uveitis, Posterior Uveitis, and Panuveitis in the VISUAL-1 and VISUAL-2 Trials.
Sheppard J; Joshi A; Betts KA; Hudgens S; Tari S; Chen N; Skup M; Dick AD
JAMA Ophthalmol; 2017 Jun; 135(6):511-518. PubMed ID: 28426849
[TBL] [Abstract][Full Text] [Related]
16. New treatment options for noninfectious uveitis.
Gomes Bittencourt M; Sepah YJ; Do DV; Agbedia O; Akhtar A; Liu H; Akhlaq A; Annam R; Ibrahim M; Nguyen QD
Dev Ophthalmol; 2012; 51():134-61. PubMed ID: 22517211
[TBL] [Abstract][Full Text] [Related]
17. Voclosporin as a treatment for noninfectious uveitis.
Schultz C
Ophthalmol Eye Dis; 2013; 5():5-10. PubMed ID: 23700374
[TBL] [Abstract][Full Text] [Related]
18. The effect of infliximab, cyclosporine A and recombinant IL-10 on vitreous cytokine levels in experimental autoimmune uveitis.
Demir T; Gödekmerdan A; Balbaba M; Türkçüoglu P; Ilhan F; Demir N
Indian J Ophthalmol; 2006 Dec; 54(4):241-5. PubMed ID: 17090875
[TBL] [Abstract][Full Text] [Related]
19. Secukinumab in the treatment of noninfectious uveitis: results of three randomized, controlled clinical trials.
Dick AD; Tugal-Tutkun I; Foster S; Zierhut M; Melissa Liew SH; Bezlyak V; Androudi S
Ophthalmology; 2013 Apr; 120(4):777-87. PubMed ID: 23290985
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of posterior noninfectious uveitis : Current situation and future developments].
Pleyer U; Pohlmann D; Stübiger N
Ophthalmologe; 2016 May; 113(5):380-90. PubMed ID: 27165275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
